Development

Articles

Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%. 

rBIO Hits Key Lab Milestone with Synthetic Production of Insulin

CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2. 

Oragenics and Avid Bioservices Collaborate on Coronavirus Vaccine

CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.

CordenPharma Expands Lipid Supply for Moderna

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Therapies for early and late treatment and passive immunization of COVID-19 are needed and can be developed using antibodies from recovered patients.

Plasma-Based Antibody Therapies Battle Against COVID-19

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Can Vaccine Development Be Safely Accelerated?

An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.

Bovine Heparin Meets Acceptable Impurity Levels

The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.

Polyplus-transfection Expands GMP Portfolio for Gene and Cell Therapy Manufacturing

Innovation in manufacturing technologies must occur to ensure the availability of gene and cell therapies.

Seeking Solutions for Large-Scale GMP Viral Vector Manufacturing

New platform technologies, advanced modeling tools, and addressing patient needs are important developments.

Advances in Engineering of Protein-Based APIs

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

API Synthesis and Manufacturing, Large Molecule